Etiometry Inc. — Department of Health and Human Services SBIR Phase II: NHLBI

Description

DESCRIPTION provided by applicant During a successful Phase effort Etiometry and Boston Childrenandapos s Hospital developed a novel Risk Monitoring System RMS to assist with the postoperative care of a vulnerable and clinically challenging neonatal population infants with surgery for congenital heart defects The system comprehensively integrates multiple physiologic signals to extract and deliver in real time actionable information about a patientandapos s physiologic state and thus support effective and timely interventions The Phase effort will deploy and integrate the system into the clinical workflow at Boston Childrenandapos s Hospital Childrenandapos s National Medical Center in Washington D C The Hospital for Sick Children Toronto and St Louis Childrenandapos s Hospital and evaluate its impact on process of care and patient outcomes In addition Etiometry will collaborate with Childrenandapos s Hospital of Philadelphia CHOP Center for Simulation Advanced Education and Innovation to test the safety efficacy usability and performance characteristics of the systemandapos s User Experience UX and will refine it to optimize its clinical utility The ultimate objective of the proposed SBIR effort will be demonstrate that the RMS can significantly affect the quality and cost of care of neonates post surgery for congenital heart defect PUBLIC HEALTH RELEVANCE Improving the care for newborns that have had surgery for correction of a heart defect has the potential not only to save lives and reduce the $ B cost of hospital care in their first year but also to affect their quality of life and societal impact as hey grow into adulthood Etiometry Risk Monitoring System will afford clinicians the ability to detect clinical risks sooner in the critical care of these babies leading to more timely intervention and better outcomes